Efficacy and safety outcomes reported in human leptospirosis studies to inform the development of a core outcome and core outcome measurement set: A systematic review
PLOS Neglected Tropical Diseases · 13.07.2026 · 20 (7) · e0013651
DOI: 10.1371/journal.pntd.0013651 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 13.07.2026. Verfasst von Nathaniel Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom. Hauptthemen laut MEDLINE: Leptospirosis, Anti-Bacterial Agents, Outcome Assessment, Health Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nagasaki University “Doctoral Program for World-leading Innovative and Smart Education” for Global Health, KENKYU SHIDO KEIHI.
Abstract (Originalsprache)
Background
Leptospirosis is a neglected bacterial zoonotic disease of global health importance, disproportionately affecting marginalised communities in tropical and subtropical settings. Current clinical trial evidence for leptospirosis treatments remains limited by heterogeneous outcome reporting and trial design. This systematic review represents the first comprehensive synthesis of outcomes, outcome measures, and treatments reported across human leptospirosis research to inform the development of a core outcome and outcome measurement set.
Methods
This systematic review was registered (COMET and PROSPERO: CRD42023397461) and conducted in accordance with a pre-published protocol. Global databases were searched for studies published on human leptospirosis without language or geographical restriction. Screening and full-text review were performed independently by two reviewers. Study characteristics, population, interventions, and reported outcomes, definitions and measurement tools were extracted. Quality and risk of bias assessments were performed. Outcomes were analysed descriptively and grouped thematically into domains.
Results
This review included 298 studies from 63 countries. There were 172 unique outcome types extracted and categorized into 23 domains. The clinical/physiological core area was the most frequently reported, with the renal and urinary domain comprising a quarter of all studies. Individual outcomes that predominated included mortality (165/298 studies), discharge from clinical services (79/298), and days of hospitalisation (77/298). Patient focused and harms outcomes were under-reported across studies. Quality assessments highlighted considerable study bias which did not improve with increasing study rigour. There were 92 outcome measures extracted and categorized into 13 thematic areas and of note was the inconsistency in types of measures, absence of patient-reported outcomes, and need for standardised and validated outcome definitions. Data captured on treatments highlighted the variability in clinical management practices worldwide. Discussion/Conclusion This review highlights the heterogeneity in outcome reporting, outcome measures, and treatments across human leptospirosis research. Establishing a consensus on core outcomes and core outcome measurements that are clinically relevant, patient-centred, and robust is needed to better support evidence-based guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
- School of Tropical Medicine and Global Health, Nagasaki University, Japan.
- Emergency Department, Royal Melbourne Hospital, Melbourne, Australia.
- Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
- Department of Clinical Medicine, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
- Global Health Trials Unit, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
ORCID-Profile: Tansy Edwards
Förderung
- Nagasaki University “Doctoral Program for World-leading Innovative and Smart Education” for Global Health, KENKYU SHIDO KEIHI
Zitieren
APA
Lee, N., Corcuera Hotz, I., Smith, C., Bailey, R., Ariyoshi, K., & Edwards, T. (2026). Efficacy and safety outcomes reported in human leptospirosis studies to inform the development of a core outcome and core outcome measurement set: A systematic review. PLOS Neglected Tropical Diseases, 20(7), e0013651. https://doi.org/10.1371/journal.pntd.0013651
Vancouver
Lee N, Corcuera Hotz I, Smith C, Bailey R, Ariyoshi K, Edwards T. Efficacy and safety outcomes reported in human leptospirosis studies to inform the development of a core outcome and core outcome measurement set: A systematic review. PLOS Neglected Tropical Diseases. 2026;20(7):e0013651. doi:10.1371/journal.pntd.0013651
BibTeX
@article{Lee2026,
author = {Lee, Nathaniel and Corcuera Hotz, Ines and Smith, Chris and Bailey, Robin and Ariyoshi, Koya and Edwards, Tansy},
title = {Efficacy and safety outcomes reported in human leptospirosis studies to inform the development of a core outcome and core outcome measurement set: A systematic review},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
volume = {20},
number = {7},
pages = {e0013651},
doi = {10.1371/journal.pntd.0013651}
}
EUVIMED